MedPath

Ketorolac Tromethamine

Ketorolac Tromethamine Tablets, USP 10mg

Approved
Approval ID

08674066-7d4b-936d-e063-6394a90abbd7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2024

Manufacturers
FDA

Northwind Pharmaceuticals, LLC

DUNS: 036986393

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ketorolac tromethamine

PRODUCT DETAILS

NDC Product Code82868-020
Application NumberANDA215788
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 1, 2024
Generic Nameketorolac tromethamine

INGREDIENTS (7)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
KETOROLAC TROMETHAMINEActive
Quantity: 10 mg in 1 1
Code: 4EVE5946BQ
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
Ketorolac Tromethamine - FDA Approval | MedPath